Literature DB >> 12859555

Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate.

G P Currie1, K Haggart, J D Brannan, D K C Lee, S D Anderson, B J Lipworth.   

Abstract

BACKGROUND: Assessment of airway hyperresponsiveness (AHR) to indirect bronchoconstrictor stimuli is a useful noninvasive tool in the evaluation of asthma and its treatment. We investigated the putative relationship in AHR between inhaled adenosine monophosphate and mannitol.
METHODS: Fifteen mild-to-moderate atopic asthmatics were evaluated. On two separate screening days, the threshold AMP concentration and threshold mannitol dose to provoke a given fall in FEV1 were measured.
RESULTS: For AMP PC20vs. mannitol PD15, the Pearsons correlation coefficient was 0.80, P < 0.001. For AMP PC15vs. mannitol PD15 and AMP PC10vs. mannitol PD10 corresponding values were 0.83, P < 0.001 and 0.68, P = 0.005.
CONCLUSIONS: There was a highly significant association between the threshold concentration of AMP and dose of mannitol causing a given fall in FEV1. Further studies are required to evaluate the relationship between inhaled mannitol and other surrogate inflammatory markers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12859555     DOI: 10.1034/j.1398-9995.2003.00226.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  3 in total

1.  Relationship of mannitol challenge to methacholine challenge and inflammatory markers in persistent asthmatics receiving inhaled corticosteroids.

Authors:  William J Anderson; Brian J Lipworth
Journal:  Lung       Date:  2012-06-09       Impact factor: 2.584

2.  The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline.

Authors:  John D Brannan; Sandra D Anderson; Clare P Perry; Ruth Freed-Martens; Anna R Lassig; Brett Charlton
Journal:  Respir Res       Date:  2005-12-09

3.  The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma.

Authors:  Graeme P Currie; Tom C Fardon; Daniel Kc Lee
Journal:  Ther Clin Risk Manag       Date:  2005-06       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.